General Hospital Practice
News, opinions and meeting coverage in hospital-based medicine.
<ѻý>FDA Panel Split Over Inhaled Antipsychoticѻý>
WASHINGTON -- An FDA advisory panel punted on the question of approval for an inhaled version of the antipsychotic drug loxapine (Adasuve) to treat agitation in bipolar and schizophrenic patients, despite the risk for respiratory side effects.
Dec 12, 2011